CAN CHRONIC MATERNAL DRUG-THERAPY ALTER THE NURSING INFANTS HEPATIC DRUG-METABOLIZING ENZYME PATTERN

Citation
Vs. Toddywalla et al., CAN CHRONIC MATERNAL DRUG-THERAPY ALTER THE NURSING INFANTS HEPATIC DRUG-METABOLIZING ENZYME PATTERN, Journal of clinical pharmacology, 35(10), 1995, pp. 1025-1029
Citations number
15
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
00912700
Volume
35
Issue
10
Year of publication
1995
Pages
1025 - 1029
Database
ISI
SICI code
0091-2700(1995)35:10<1025:CCMDAT>2.0.ZU;2-A
Abstract
This study was carried out to investigate whether minute quantities of maternal drugs ingested over an extended period of time by a breast-f eeding infant can alter the activity pattern of the infant's hepatic d rug metabolizing enzyme (HDME). The HDME activity patterns of 12 breas t-fed infants whose mothers were not on drug therapy were compared wit h those of 11 infants whose mothers had been taking 30 mu g levo-norge sterel daily for 90 to 195 days (oral contraceptives group) and of 10 infants whose mothers had been taking ethambutol and isoniazid daily s ince pregnancy (tuberculosis group). As 6 beta hydroxycortisol in urin e is considered to be a good and acceptable reflector of HDME activity , it was estimated from the infants' urine using enzyme-linked immunos orbent assay (ELISA) technique. A comparison of the patterns between 9 0 days of age and 195 days of age of the infants in the control group and the two study groups indicated an increase from 36.6 ng/mL to 58.4 ng/mL at 195 days in the control group. An initial decrease from 36.6 ng/mL to 26.2 ng/mL was noted with commencement of maternal levo-norg esterel therapy, followed by a slow and steady rise to 47.8 ng/mL at 1 95 days of age, with a shift in the peak from 120 to 135 days of infan ts age in the oral contraceptive group. A suppressed pattern with decr eased levels of 6 beta hydroxycortisol ranging from 19.3 ng/mL to 26.5 ng/mt at 195 days was found in the tuberculosis group. The data were analyzed by two-way analysis of variance (ANOVA) coupled with Duncan's Multiple range test. Both treatment groups showed significant differe nces from the control group at the 0.050 level. The HDME plays on impo rtant role in determining the final outcome of any drug in humans, as it controls the metabolism of drugs. Hence, alterations in its activit y caused by the transfer of maternal drugs over a prolonged period of time could pose a serious problem to nurslings when they require drugs for their own benefit.